Biphasic Expression of Atypical Chemokine Receptor (ACKR) 2 and ACKR4 in Colorectal Neoplasms in Association with Histopathological Findings
Facilitating resolution of inflammation using atypical chemokine receptors (ACKR) as an anticancer strategy is considered but requires a deeper understanding of receptor role in carcinogenesis. We aimed at transcriptional analysis (RTqPCR) of <i>ACKR2</i> and <i>ACKR4</i> exp...
Main Authors: | Paulina Lewandowska, Jaroslaw Wierzbicki, Marek Zawadzki, Anil Agrawal, Małgorzata Krzystek-Korpacka |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-12-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/11/1/8 |
Similar Items
-
Emerging Roles of the Atypical Chemokine Receptor 3 (ACKR3) in Cardiovascular Diseases
by: Vincent Duval, et al.
Published: (2022-06-01) -
Large chemokine binding spectrum of human and mouse atypical chemokine receptor GPR182 (ACKR5)
by: Remy Bonnavion, et al.
Published: (2023-11-01) -
Monocyte Chemotactic Proteins (MCP) in Colorectal Adenomas Are Differently Expressed at the Transcriptional and Protein Levels: Implications for Colorectal Cancer Prevention
by: Jarosław Wierzbicki, et al.
Published: (2021-11-01) -
The Role of Atypical Chemokine Receptor D6 (ACKR2) in Physiological and Pathological Conditions; Friend, Foe, or Both?
by: Arezoo Gowhari Shabgah, et al.
Published: (2022-05-01) -
Identification of ACKR4 as an immune checkpoint in pulmonary arterial hypertension
by: Chen-Yu Jiang, et al.
Published: (2023-06-01)